According to Zhitong Finance App News, Da Ren Tang (600329.SH) released its 2026 semi-annual report. During the reporting period, the company achieved operating income of 2,455 billion yuan, a year-on-year decrease of 7.39%; net profit attributable to shareholders of listed companies of 645 million yuan, a year-on-year decrease of 66.55%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses of 641 million yuan, an increase of 7.43% over the previous year; and basic earnings per share of 0.84 yuan.

In the first half of 2026, the company achieved operating income of 2,455 billion yuan; net profit attributable to shareholders of the parent company decreased by 66.55% year-on-year, mainly due to the company selling 12% of the shares of the associated company Sino-US Tianjin Schke Pharmaceutical Co., Ltd. and net profit after tax of 1.31 billion yuan. There were no such non-recurring events in the current period.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.